TargetRx

China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 2
Next date
TGRX-1942, Phase 1 trial completes
Drugs
4
in active trials · 7 in all
Trials
9 active
14 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
—
Phase 3 1 May 2030Phase 3 trial completes
ALK/ROS1 inhibitor
Phase 3 —
—
Phase 1/2 —
—
Phase 1 Feb 2027Phase 1 trial completes

About

No active trial
cycle 1: reference drug, cycle 2: reference drug, cycle 3: reference drug
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021

Follow TargetRx

Following is part of Solo: you see every change to TargetRx the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in